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Introduction
Nonketotic hyperglycinemia (NKH) is a rare, autosomal-
recessive, inborn error of  glycine degradation caused by a 
defect of  the glycine cleavage system (1). This defect causes 
large quantities of  glycine to accumulate in all body tissues, 
particularly in the central nervous system (CNS). In classi-
cal neonatal-onset NKH, excessive CNS glycine levels lead 
to lethargy, poor feeding, hypotonia, and hiccups that de-
velop within hours to days after birth. Symptoms progress 
to seizures, apnea, respiratory insufficiency, and coma, and 
typically lead to death between 3 and 5 months of  age (2). 
Complicating the diagnosis and management of  classical 
NKH in neonates are atypical and transient NKH variants 
that present with milder clinical symptoms and have vari-
able neurological outcome, including complete resolution of 
neurologic symptoms in the transient form (2-4).
Proton (1H) magnetic resonance (MR) spectroscopy al-
lows noninvasive measurement of  brain glycine concentra-
tions and has been described as a useful tool for diagnosis 
as well as for monitoring of  the effects of  therapeutic inter-
ventions in classical NKH (5-9). However, glycine is not 
reliably detected with MR spectroscopy in healthy brains or 
in medical conditions not associated with excessive glycine, 
such as psychiatric illnesses. We report a case in which 1H-
MR spectroscopy facilitated early diagnosis of  neonatal-
onset NKH that was subsequently confirmed with meta-
bolic studies and genetic testing. In medical centers where 
metabolic studies are not readily available, 1H-MR spec-
troscopy may assist with early diagnosis and management 
of  NKH. 
Case report
A male neonate delivered spontaneously at full term to a 
23-year-old gravida 2, para 1 mother with an unremarkable 
pregnancy. The parents were from Somalia and were non-
consanguineous. There was no family history of  metabolic 
disease, and the neonate’s male sibling was developmentally 
normal. The neonate did not appear dysmorphic. He had a 
birth weight of  4.098kg (84th percentile) and head circum-
ference of  35 cm (44th percentile). At 3 days, he was noted 
to feed poorly, with decreased tone and reflexes noted on 
exam. He was admitted to the neonatal intensive care unit 
for a sepsis workup. Cranial ultrasonography, performed to 
exclude the possibility of  hemorrhage, revealed a small 
right-sided choroid plexus cyst and partial agenesis of  cor-
pus collosum. Spontaneous and stimulus-provoked myo-
clonic jerks and intermittent hiccups were observed. He 
became progressively lethargic and unresponsive, with cen-
tral hypotonia. At 4 days, amino acid analysis of  the cere-
bral spinal fluid (CSF) and plasma was requested to evalu-
ate for a metabolic disorder. Liver studies and an ammonia 
level were normal. The septic workup, which included a 
blood culture and CSF bacterial and viral cultures, was 
negative. Bedside electroencephalographic monitoring was 
abnormal, demonstrating diffuse cortical dysfunction and 
partial seizures. The neonate displayed progressive en-
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cephalopathy and respiratory insufficiency and so was 
placed on mechanical ventilation at 6 days of  age. 
MR imaging of  the brain was performed at 6 days of  
age, on a Philips Acheiva Scanner (version 2.6.1, 3 Tesla) 
using a standard quadrature head coil. Since the neonate 
was encephalopathic, anesthesia was not required to mini-
mize movement during the imaging study. Sagittal 3D 
gradient-echo T1-weighted images were acquired with 
TR/TE of  8.2/3.8 ms, FOV 150 X 150 mm, 80 slices, 
section thickness of  1mm, no gap, and an imaging matrix 
of  160X160. Axial fast spin-echo T2-weighted 4800/90 ms 
(TR/TEeff) images were obtained with an echo-train 
length of  11, a field of  view of  150X150 mm, an in-plane 
imaging matrix of  480 X 480, and a 3-mm section thick-
ness with a 0.3-mm gap. Fluid-attenuated inversion-
recovery images were acquired with TR/TE/TI 12000/
140/2850 ms, and with the same resolution and positioning 
as with the T2-weighted images. Axial diffusion-weighted 
MR images were acquired with an in-plane field of  view of 
166 X 166 mm, 128 X 128 matrix size, section thickness/
gap 4/0.4 mm, 2 diffusion gradient b values of  0 and 1000, 
and TR/TE 2738/57.75 ms; section positions were the 
same as in the axial T1- and 
T2-weighted sequences. From 
the acquired data, the average 
apparent diffusion coefficient 
was calculated. The MR im-
aging revealed a small intra-
ventricular hemorrhage in the 
lateral ventricles and partial 
agenesis of  the corpus callo-
sum (Fig. 1).
Due to clinical suspicion for 
NKH, 1H-MR spectroscopy 
to look for elevated brain 
glycine was performed. 
Single-voxel spectroscopy (us-
ing the PRESS pulse sequence 
with voxel localization [TR 
2000 ms, 1024 FID points, 
spectral width 2000 Hz, 128 
averages, voxel size 20 X 20 X 
20 mm] over the midline su-
perior parietal lobe) was per-
formed with TE 35, 144, and 
288. 
1H-MR spectroscopy data 
reconstruction was conducted 
offline using software devel-
oped by one of  the authors 
(TR) in Fortran, which pre-
pares the data for LCModel 
processing (10). Spectra fit was 
conducted using LCModel, an 
automated technique that uses 
prior knowledge for model fits. 
A water spectrum of  the same 
region was also acquired (without water suppression) for 
quantification used in the LCModel software. LCModel 
was used using a basis set that was prepared using phan-
toms with known concentrations of  brain metabolites, as 
detailed in the LCModel manual (11). The absolute con-
centrations (millimoles; mmol) of  choline, N-acetyl aspa-
rate, glycine, and creatine were computed. Tissue fractions 
were calculated by summing the CSF voxels within the 1H-
MR spectroscopy voxel, which were segmented out (seg-
mentation was performed using FSL’s FAST software, Ox-
ford, UK, with 4 classification model) using the high-
resolution three-dimensional anatomical image and then 
dividing the brain volume (total volume - CSF volume) by 
the total 1H-MR spectroscopy voxel volume. The results of 
this segmentation within the MR spectroscopy voxel are 
reported as a fraction to the whole voxel volume as follows: 
gray matter 0.35, white matter 1 (partly myelinated) 0.30, 
white matter 2 (unmyelinated) 0.29, CSF 0.048. Free-
induction decays (FIDs) were used as input into the 
LCModel software and were filtered with a finite discrete 
convolution to account for field inhomogeneities and eddy 
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Figure 1. Neonate with nonketotic hyperglycinemia. T1-weighted (upper left), T2-weighted 
(upper right), diffusion-weighted (lower left), and FLAIR (lower right) images of this patient, 
all at the same slice location. These images reveal partial agenesis of the corpus callosum 
(black arrow).
currents. FIDs were zero- and first-order phase-corrected. 
Absolute concentrations (mmol/kg wet weight) were ob-
tained by scaling the in vivo spectrum to the unsuppressed 
water peak. The absolute concentrations of  the 1H-MR 
spectroscopy metabolites seen in our patient were glycine 
(11.8), choline (2.47), creatine (7.66), N-acetylaspartate 
(5.74), and lactate (2.45). There could have been overesti-
mation of  the glycine concentration in the LCmodel output 
due to overlap of  the inositol resonance at 3.55 ppm using 
TE=35 ms. The glycine concentration was also estimated 
from the spectrum at TE 288ms, and this resulted in a 
much smaller concentration of  glycine ~ 6 mM (assuming 
a similar T2 relaxation time as creatine). An elevated 
glycine peak at 3.55 ppm was noted (Fig. 2 and Fig. 3), sup-
porting the diagnosis of  NKH.
CSF and plasma amino acid analysis, which became 
available after the 1H-MR spectroscopy study, revealed 
glycine levels of  342 (normal, 1-11) μmol/mL and 1419 
(normal, 106 -318) μmol/mL, respectively. The CS- to-
plasma glycine concentration ratio was 0.24 (normal, < 
0.08), confirming the diagnosis of  NKH. Urine organic 
acid analysis was negative. The neonate was treated with 
dextromethorphan (30 mg/kg/day), phenobarbital (7 mg/
kg/day), and sodium benzoate (500 mg/kg/day). His level 
of  consciousness improved slowly over several days, and at 
19 days of  age he was extubated from mechanical ventila-
tion. Follow-up weekly amino acid analysis revealed overall 
decreased plasma glycine concentrations with periodic ele-
vations. DNA testing demonstrated that the infant had a 
homozygous missense mutation (c. 2846C>T) in the 
GLDC gene, encoding the enzyme glycine decarboxylase 
(P-protein), namely p.P949L in exon 24. He is currently five 
months old, on a glycine-restricted diet, with ongoing 
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Figure 2. Neonate with nonketotic hyperglycinemia. Proton MRIs (right) and spectra (left) obtained from an infant with nonke-
totic hyperglycinemia. T1-weighted images with voxel location (white boxes) of the MR spectroscopy showing all three recon-
structed planes (top, sagittal; middle, coronal; bottom, axial). The T1-weighted images were acquired with a 3D gradient-echo 
pulse sequence with TR/TE of 8.2/3.8 ms, FOV 150 X 150 mm, 80 slices, section thickness of 1mm, no gap, and an imaging 
matrix of 160 X 160. Short (TE 35 ms) and long (TE 144 ms) proton (1H) MR spectra obtained from the parietal show a promi-
nent singlet at 3.55 ppm (arrow), which is assigned to glycine and an elevated peak at 1.28 ppm (arrow), which is assigned to 
lactate. Lactate is visible at TE 35 as an upright peak, at TE 144 as an inverted peak, and at TE 288 ms as an upright peak. 
This change in lactate with echo time is a way to identify lactate due to its j-modulation properties as a function of echo time 
(which causes the inversion of the peak at 1.33ppm at TE 144 ms).
medical issues including feeding problems, poor growth, 
recurrent vomiting, and seizures.
Discussion
The neonate in our report had partial agenesis of  the 
corpus callosum, initially noted on cranial ultrasound. This 
finding, along with his clinical presentation, particularly the 
recurrent episodes of  hiccups, was highly suspicious for the 
diagnosis of  NKH. This prompted us to perform early 1H-
MR spectroscopy to look for an elevated glycine peak, 
which has been previously reported (5-9). Glycine is nor-
mally not observed in 1H-MR spectroscopy of  the brain, 
but in our case it was the highest peak shown (Fig. 2). The 
glycine peak at 3.55 ppm was most elevated (as compared 
with nearby metabolites) at a short TE of  35 ms, compared 
to longer TEs of  144 and 288 ms. .
The absolute concentrations of  the 1H-MR spectroscopy 
metabolites choline, creatine, and N-acetylaspartate seen in 
our patient were abnormal. These values resemble those 
seen in neonates with encephalopathy from cerebral 
hypoxic-ischemic injury associated with severely abnormal/
fatal outcomes (death or major impairment with disability 
on neurologic assessment and/or developmental quotient < 
75 based on examination at one year) compared to control 
infants (12). In addition to elevated brain glycine, 1H-MR 
spectroscopy demon-
strated an elevated lac-
tate peak. The increased 
lactate peak observed 
may reflect anaerobic 
glycolysis of  brain tissue, 
probably caused by res-
piratory insufficiency 
and hypoxia (8). The 
absolute concentration of 
lactate was lower than 
values reported by 
Cheong et al (12) in neo-
nates with encephalopa-
thy secondary to perina-
tal cerebral hypoxic-
ischemic injury; however, 
this may be secondary to 
differences in the under-
lying etiology of  brain 
injury and the timing of  
the of  1H-MR spectros-
copy studies.
1H-MR spectroscopy 
may be useful in provid-
ing valuable diagnostic 
information and early 
treatment in patients 
with clinical presenta-
tions suspicious for 
NKH. The diagnosis of  
NKH was supported by 
the 1H-MR spectroscopy 
findings in our case report, which were available before 
metabolic study results returned. 1H-MR spectroscopy has 
also been advocated as a noninvasive diagnostic tool for 
monitoring brain glycine levels in patients with NKH (13) 
and in differentiating the diagnosis of  NKH in patients 
with other disorders associated with elevated plasma glycine 
levels (9). Elevated glycine levels are seen in other disorders 
on 1H-MR spectroscopy, such as central neurocytoma (14) 
and in oligodendroglial gliomatosis (15), so clinical correla-
tion and metabolic studies are also needed to confirm the 
diagnosis of  NKH. 
Despite diagnosis with 1H-MR spectroscopy and meta-
bolic studies, prognostication can be difficult in neonatal 
NKH. This is due to transient and atypical variants that 
display similar clinical presentations to classical NKH with 
hypotonia, seizures, and apneic episodes that may require 
assisted ventilation (3, 16). Unlike neonates with classical 
NKH, neonates with atypical and transient NKH may have 
improvement of  symptoms over time, with subsequent 
normal psychomotor development in some cases. It is un-
clear if  early therapeutic intervention affects long-term 
outcomes in these cases. The occurrence of  patients with 
apparent transient forms of  NKH adds uncertainty to the 
prediction of  clinical outcome, especially regarding deci-
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Figure 3. Neonate with nonketotic hyperglycinemia. Graphic output from LCmodel showing the 
actual spectral data and the fitted data at TE 35 ms.
sions of  withholding or withdrawing therapy in affected 
neonates (4).
In summary, our case demonstrates that 1H-MR spec-
troscopy may facilitate early diagnosis of  NKH before the 
availability of  metabolic and genetic test results. Timely use 
of  1H-MR spectroscopy may identify and help guide clini-
cal management in neonates with suspected NKH. 
Acknowledgments
We gratefully acknowledge the help of  Jeff  Stevenson, 
who helped with MR spectroscopic analysis.
References
1.	 Nakai T, Nakagawa N, Maoka N, Masui R, Kuramitsu 
S, Kamiya N. Structure of  P-protein of  the glycine 
cleavage system: implications for nonketotic hyper-
glycinemia. EMBO J 2005;24:1523-1536. [PubMed]
2. 	 Lang TF, Parr JR, Matthews EE, Gray RG, Bonham 
JR, Kay JD. Practical difficulties in the diagnosis of  
transient non-ketotic hyperglycinaemia. Dev Med 
Child Neurol 2008;50:157-159. [PubMed]
3. 	 Dinopoulos A, Matsubara Y, Kure S. Atypical variants 
of  nonketotic hyperglycinemia. Mol Genet Metab 
2005;86:61-69. [PubMed]
4. 	 Boneh A, Allan S, Mendelson D, Spriggs M, Gillam 
LH, Korman SH. Clinical, ethical and legal considera-
tions in the treatment of  newborns with non-ketotic 
hyperglycinaemia. Mol Genet Metab 
2008;94:143-147. [PubMed]
5. 	 Sener RN. Nonketotic hyperglycinemia: diffusion 
magnetic resonance imaging findings. J Comput Assist 
Tomogr 2003;27:538-540. [PubMed]
6. 	 Bekiesiniska-Figatowska M, Rokicki D, Walecki J. MRI 
in nonketotic hyperglycinaemia: case report. Neurora-
diology 2001;43:792-793. [PubMed]
7. 	 Viola A, Chabrol B, Nicoli F, Confort-Gouny S, Viout 
P, Cozzone PJ. Magnetic resonance spectroscopy study 
of  glycine pathways in nonketotic hyperglycinemia. 
Pediatr Res 2002;52:292-300. [PubMed]
8. 	 Choi CG, Lee HK, Yoon JH. Localized proton MR 
spectroscopic detection of  nonketotic hyperglycinemia 
in an infant. Korean J Radiol 2001;2:239-242. [Pub-
Med]
9. 	 Huisman TA, Thiel T, Steinmann B, Zeilinger G, Mar-
tin E. Proton magnetic resonance spectroscopy of  the 
brain of  a neonate with nonketotic hyperglycinemia: in 
vivo-in vitro (ex vivo) correlation. Eur Radiol 
2002;12:858-861. [PubMed]
10. 	Provencher SW. Estimation of  metabolite concentra-
tions from localized in vivo proton NMR spectra. 
Magn Reson Med 1993;30:672-679. [PubMed]
	 Provencher SW. LcModel and LcMgui User's Manual 
2000. Available from: 
http://s-provencher.com/pages/lcm-manual.shtml. 
12.	 Cheong JL, Cady EB, Penrice J, Wyatt JS, Cox IJ, 
Robertson NJ. Proton MR spectroscopy in neonates 
with perinatal cerebral hypoxic-ischemic injury: me-
tabolite peak-area ratios, relaxation times, and absolute 
concentrations. AJNR Am J Neuroradiol 
2006;27:1546-1554. [PubMed]
13. 	Suzuki Y, Ueda H, Toribe Y. [Proton MR spectroscopy 
of  nonketotic hyperglycinemia]. No To Hattatsu 
2001;33:422-425. [PubMed]
14. 	Yeh IB, Xu M, Ng WH, Ye J, Yang D, Lim CC. Cen-
tral neurocytoma: typical magnetic resonance spectros-
copy findings and atypical ventricular dissemination. 
Magn Reson Imaging 2008;26:59-64. [PubMed]
15. 	Gutowski NJ, Gomez-Anson B, Torpey N, Revesz T, 
Miller D, Rudge P. Oligodendroglial gliomatosis cere-
bri: (1)H-MRS suggests elevated glycine/inositol levels. 
Neuroradiology 1999;41:650-653. [PubMed]
16. 	Aliefendioglu D, Tana Aslan A, Coskun T, Dursun A, 
Cakmak FN, Kesimer M. Transient nonketotic hyper-
glycinemia: two case reports and literature review. Pe-
diatr Neurol 2003;28:151-155. [PubMed]
Detection of nonketotic hyperglycinemia in a neonate using proton magnetic resonance spectroscopy 
RCR Radiology Case Reports | radiology.casereports.net 5 2009 | Volume 4 | Issue 4  
